News Daily News Growing Gap in CVD Risk Factor Control Between Rich and Poor Michael O'Riordan June 08, 2017
News Daily News ‘Sizeable’ Segment of Public, Even When at High CVD Risk, Feels No Need to Improve Health Michael O'Riordan May 04, 2017
News Daily News Trans Fat Ban Led to Tangible CVD Benefits, New York State Analysis Shows Michael O'Riordan April 12, 2017
News Daily News Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients Yael L. Maxwell April 11, 2017
News Daily News Midlife Vascular Risk Factors Linked to Amyloid Plaques in Alzheimer’s Alison Palkhivala April 11, 2017
News Daily News ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events Michael O'Riordan April 04, 2017
News Daily News A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits Michael O'Riordan March 08, 2017
News Daily News Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes Yael L. Maxwell February 14, 2017
News Daily News Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint Michael O'Riordan February 03, 2017
News Daily News Women Without Diabetes Fare as Poorly as Diabetic Men Post-PCI L.A. McKeown January 30, 2017
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Daily News FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes Shelley Wood December 02, 2016
News Daily News PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk Michael O'Riordan December 01, 2016
News Daily News Las Variantes del Gen PCSK9 se asocian a Niveles Más Bajos de Colesterol LBD y a un Mayor Riesgo de Diabetes Michael O'Riordan December 01, 2016
News Daily News Más Quelación: Se Aprueba el Ensayo TACT2 para el Controvertido Tratamiento Post-IM en Pacientes Diabéticos Shelley Wood September 28, 2016
News Daily News Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes Shelley Wood September 28, 2016
News Daily News Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6 Michael O'Riordan September 16, 2016